(888) 508-6752
Chicago
Case Types We Handle
Edwardsville
Case Types We Handle
St. Louis
Case Types We Handle

Illinois

Alton
Belleville
Fairview Heights
Collinsville
Glen Carbon
O'Fallon
Granite City
Peoria
East Alton
Decatur
All Illinois Locations

Missouri

St Charles
Ballwin
Brentwood
Chesterfield
Clayton
Ferguson
Florissant
Hazelwood
Kirkwood
Maryland Heights
All Missouri Locations
Other Dangerous Drugs
Dangerous Drugs
Other Defective Products
Defective Products
Other Exposure Cases
Chemical Exposure
About
TorHoerman Law

Our firm is about people. That is our motto and that will always be our reality.

We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.

At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.

Learn more
Contact Us
Chicago Office
Edwardsville Office
St. Louis Office
About
Our Team

Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.

The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.

Our team is what has made TorHoerman Law a very special place since 2009.

Learn more
Contact Us
Chicago Office
Edwardsville Office
St. Louis Office
About
Resources
Other Resources
Featured Posts

New York Woman has Filed a Class-Action Lawsuit Against the Developers of Weight Loss Drug Belviq

Belviq Lawsuit »
New York Woman has Filed a Class-Action Lawsuit Against the Developers of Weight Loss Drug Belviq

The U.S. Food and Drug Administration in February requested that weight-loss drug Belviq be pulled from the market due to cancer concerns. While Eisai Inc., Belviq manufacturer, complied with the FDA’s request for removal, the lawsuit filed by Barbara Zottola states “by that point, unfortunately, the damage had already been done.”

Concerns regarding the safety of Belviq, the brand name of lorcaserin, are not new. The FDA initially rejected an application for approval of lorcaserin “due to safety concerns, specifically cancer risk,” according to the complaint.

A study ran by Arena Pharmaceuticals Inc. in 2007 showed that lorcaserin caused rare and aggressive tumors in rats. Despite those results, Arena and Eisai resubmitted the application for lorcaserin as Belviq in 2012 and the FDA approved it in 2013 for use by patients with weight-related health conditions.

Concurrently, the FDA stipulated that Eisai must conduct long-term clinical studies to assess the risk of any cardiovascular complications. However, the drug was already being marketed and prescribed to patients while the study was ongoing.

The FDA reported that patients in the study who took Belviq were more often diagnosed with cancer. Zottola believes that Belviq never would have been approved if Eisai and Arena told the FDA about the cancer risks identified in the initial rat study.

The complaint asks the federal court to certify a class of hundreds of thousands of people across the country who purchased Belviq. The lawsuit seeks damages for alleged breach of an implied warranty, deceptive acts, false advertising, unjust enrichment, fraud, and conversion.

If you or a loved one have taken Belviq and have been diagnosed with cancer, you may be entitled to financial compensation.

Share

Litigation Updates

Cancer Claims Survive, Design Defect Does Not, In MO Belviq Lawsuit

October 18, 2021
Learn More

October 18, 2021

Cancer Claims Survive, Design Defect Does Not, In MO Belviq Lawsuit

New York Woman has Filed a Class-Action Lawsuit Against the Developers of Weight Loss Drug Belviq

June 11, 2020
Learn More

June 11, 2020

New York Woman has Filed a Class-Action Lawsuit Against the Developers of Weight Loss Drug Belviq

CLIENT REVIEWS

quotation
Lisa

From the moment I met them, it felt like a weight lifted – TorHoerman Law was confident, ready to fight, and truly cared about me as a person.

quotation
Jane

Rear-ended on my way to work, I ended up a patient in my own ER – TorHoerman Law took over the insurance nightmare so I could focus on getting better.

quotation
TJ

After months of chiropractic bills from an accident that wasn’t my fault, TorHoerman Law got involved and made the whole process easy – they treat you like family, not a number.

quotation
Richard "Doc" Holliday

After a hit-and-run left me with a shattered leg and no idea where to turn – TorHoerman Law took over everything, got me every dollar available, and made me feel like family.

quotation
Trish Jones

I have had many speed bumps to get over on information needed to file my claim that has had me stressing out several times, but once I have gotten in touch with TorHoerman Law I always come out with most of my problems handled. Nikki has been very much helpful in aiding me with my complaint and never lets me go feeling like I’m clueless as to what to do next. She listens and responds very efficiently and with very positive attitude and that’s always helpful. Thanks TorHoerman Law for your advice and support I appreciate all y’all have done for me.

quotation
Amari Raglin

I was in a car accident and went to the Personal Injury Team at TorHoerman Law. I met with Kristie Stephens and she was awesome, keeping me informed of what was going on, what to expect and not to hesitate to call if I need any questions answered. The staff I came in contact over the phone was Kristine Stephens, and she guided me through the whole process. I suggest the Personal Injury Team at TorHoerman Law for anybody that needs help with legal action.

quotation
Tom Lewis

TorHoerman Law was responsible for handling a medical case for our family. I was extremely impressed with their professionalism and ability to react quickly. They also did a nice job keeping us updated with the case throughout the process. This was the first time experiencing a situation like this and Tor Hoerman law did an excellent job from start to finish.